How much funding has 3T Biosciences raised?

3T Biosciences has raised $40.0M in total funding, most recently a Series A round.

When was 3T Biosciences founded?

3T Biosciences was founded in 2017.

Where is 3T Biosciences headquartered?

3T Biosciences is headquartered in South San Francisco, California, United States.

What industry is 3T Biosciences in?

3T Biosciences operates in Biotech, Immunotherapy.

3T Biosciences

Q: Who are 3T Biosciences's investors?

3T Biosciences's investors include Westlake Village BioPartners, Lightspeed VP.

TCR Target ID And Therapeutic Discovery

South San Francisco, United States · Founded 2017 · $40.0M raised

Biotech

Immunotherapy

Headquarters: South San Francisco, California
Founded: 2017
Business Model: B2B
Website: 3tbiosciences.com

Total Funding: $40.0M
Last Round: $40.0M Series AAug 2022
Rounds: 1

About

Immunotherapy company developing next-generation TCR-based therapeutics for cancer treatment.

Summary

3T Biosciences is a Biotech company based in South San Francisco, United States, founded in 2017. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Aug 2022. Investors include Westlake Village BioPartners and Lightspeed VP.

LinkedIn X (Twitter)